Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-25

FDA Approved: EPLERENONE — Original Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves Westminster Pharmaceuticals' original ANDA for EPLERENONE (generic eplerenone), providing a generic option for hypertension and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eplerenone (eplerenone)

Snippet

ORIG AP for EPLERENONE (EPLERENONE)